Biotechnology News and Research

RSS

Study reveals wastewater as potential origin for mobile antibiotic resistance genes

Researchers found new evidence that wastewaters are a feasible environment for mobilizing antibiotic resistance genes.

29 Mar 2023

Johns Hopkins Medicine surgeons to receive $21.4 million to advance xenotransplantation research

As part of the worldwide effort to facilitate a research and clinical pathway toward successful xenotransplantation - the transplantation of living cells, tissues and organs from one species to another - two Johns Hopkins Medicine surgeons, Kazuhiko Yamada, M.D., Ph.D., and Andrew Cameron, M.D., Ph.D., will receive a total of $21.4 million in funding over the next two years under two sponsored research agreements with biotechnology company United Therapeutics Corporation.

29 Mar 2023

Lab-made antibodies may be able to cure people infected with yellow fever

New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.

29 Mar 2023

Mouse avatars could help design more effective and personalized therapies for multiple myeloma

An international group of researchers, led by Dr. José Ángel Martínez-Climent at the Cima University of Navarra, has created mouse avatars of patients with multiple myeloma to study and develop personalized treatments against this blood cancer, the second most frequent hematological cancer and incurable in most cases.

29 Mar 2023

Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

A team of scientists led by the Department of Energy's Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.

28 Mar 2023

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

Researchers have designed a molecule that slows the effects of one of SARS-CoV-2's more dangerous components – an enzyme called a protease that cuts off the immune system's communications and helps the virus replicate.

28 Mar 2023

Developers of gene therapies can utilize FDA guidance to prepare ODD or RPDD applications

Providing an overview of the submissions process and examples of U.S. Food and Drug Administration (FDA) applications for Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD), a new article can help developers of gene therapies for rare genetic diseases.

27 Mar 2023

Microbes living in the human body may be acting as a reservoir for antibiotic resistance

The community of microbes living in and on our bodies may be acting as a reservoir for antibiotic resistance, according to new research from the Earlham Institute and Quadram Institute in Norwich.

27 Mar 2023

BioEcho launches EchoLUTION™ FFPE DNA Kit for a simplified DNA extraction from FFPE samples

BioEcho Life Sciences, the biotechnology company delivering rapid and sustainable nucleic acid extraction products, announces the EchoLUTION FFPE DNA Kit release, for an innovative way to extract DNA from any kind of FFPE sample.

From BioEcho Life Sciences GmbH 27 Mar 2023

SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing a recombinant enzyme derived from maggots which aims to accelerate wound debridement, has announced the completion of its GBP 10.9m (c. USD 13.3m) Series B investment round. The funding round was led by Seneca Partners and also included industry veterans, institutional venture and strategic investors, including BRAIN Biotech AG, EVA Pharma, Jonathan Milner, and Wealth Club.

From SolasCure 27 Mar 2023

Study outlines a meta-scale approach to quantifying the human proteome

A major puzzle of biology is that while the human genome contains roughly 20,000 genes, many comparatively primitive organisms - including the universally-studied worm C. elegans - have almost the same number of genes.

23 Mar 2023

Ingenza celebrates 20 years of innovation

Edinburgh-based Ingenza, a pioneer in engineering biology, is delighted to celebrate its 20th anniversary this month.

From Ingenza Ltd 23 Mar 2023

Girls born to obese mothers have a high risk of developing obesity

Women with obesity may share risk for the disease with their daughters, but not their sons, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

21 Mar 2023

Snapping at new biotech breakthroughs with Gator Pro

In this interview, we speak to Subodh Nimkar, Marketing Director at Gator Bio, about their latest technology, Gator Pro which allows for fast, reliable, and high-quality data.

From Gator Bio, Inc. 21 Mar 2023

INTEGRA Biosciences acquires Miroculus to accelerate genomics

INTEGRA Biosciences is delighted to announce that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols.

From INTEGRA Biosciences 20 Mar 2023

Research shows the role of PCYT2-mediated lipid synthesis in vertebrate muscle health

Muscle degeneration, the most prevalent cause of frailty in hereditary diseases and aging, could be caused by a deficiency in one key enzyme in a lipid biosynthesis pathway.

20 Mar 2023

Nanopath becomes the first winner of INTEGRA supports start-ups competition

Nanopath, a molecular diagnostics start-up, has been chosen as the first winner of the recently launched INTEGRA supports start-ups competition, receiving 30 EVOLVE manual pipettes to help the company further develop its novel technology and translate the method to the clinic.

From INTEGRA Biosciences 20 Mar 2023

Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection

Owlstone Medical, the global leader in Breath Biopsy® announced that it has entered into a Research Agreement with Bicycle Therapeutics plc.

15 Mar 2023

Women-focused diagnostics start-up wins INTEGRA Biosciences’ EVOLVE pipettes

Nanopath has been chosen as the first winner of the recently launched INTEGRA supports start-ups competition.

From INTEGRA Biosciences 15 Mar 2023

Understanding how cells adjust in real time to withstand stresses on our health

Every minute of every day, our body adapts to meet the needs of each moment. When we binge on carbs, exercise, or become sick, chemical reactions inside our cells switch on, slow down, or shift strategy so that we have the energy and strength we need.

14 Mar 2023

Biotechnology News and Research

Study reveals wastewater as potential origin for mobile antibiotic resistance genes

Johns Hopkins Medicine surgeons to receive $21.4 million to advance xenotransplantation research

Lab-made antibodies may be able to cure people infected with yellow fever

Mouse avatars could help design more effective and personalized therapies for multiple myeloma

Newly designed molecule disrupts the infection mechanism of SARS-CoV-2

New molecule slows the effects of one of SARS-CoV-2's more dangerous components

Developers of gene therapies can utilize FDA guidance to prepare ODD or RPDD applications

Microbes living in the human body may be acting as a reservoir for antibiotic resistance

BioEcho launches EchoLUTION™ FFPE DNA Kit for a simplified DNA extraction from FFPE samples

SolasCure announces final closing of GBP 10.9m (c. USD 13.3m) Series B fundraise to advance wound care innovation

Study outlines a meta-scale approach to quantifying the human proteome

Ingenza celebrates 20 years of innovation

Girls born to obese mothers have a high risk of developing obesity

Snapping at new biotech breakthroughs with Gator Pro

INTEGRA Biosciences acquires Miroculus to accelerate genomics

Research shows the role of PCYT2-mediated lipid synthesis in vertebrate muscle health

Nanopath becomes the first winner of INTEGRA supports start-ups competition

Owlstone Medical Enters Partnership with Bicycle Therapeutics for the Development of Antigen-Targeted EVOC Probes for Early Cancer Detection

Women-focused diagnostics start-up wins INTEGRA Biosciences’ EVOLVE pipettes

Understanding how cells adjust in real time to withstand stresses on our health

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News